A detailed history of Spartan Planning & Wealth Management transactions in Amgen Inc stock. As of the latest transaction made, Spartan Planning & Wealth Management holds 1,077 shares of AMGN stock, worth $301,635. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,077
Previous 1,271 15.26%
Holding current value
$301,635
Previous $341,000 9.09%
% of portfolio
0.35%
Previous 0.41%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 12, 2024

SELL
$255.7 - $288.46 $49,605 - $55,961
-194 Reduced 15.26%
1,077 $310,000
Q3 2023

Nov 17, 2023

SELL
$218.65 - $271.46 $71,717 - $89,038
-328 Reduced 20.51%
1,271 $341,000
Q4 2022

Feb 01, 2023

BUY
$229.03 - $291.01 $366,218 - $465,324
1,599 New
1,599 $419,000
Q2 2022

Aug 10, 2022

BUY
$230.71 - $256.74 $168,187 - $187,163
729 Added 66.15%
1,831 $445,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $241,635 - $267,312
1,102 New
1,102 $266,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Spartan Planning & Wealth Management Portfolio

Follow Spartan Planning & Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spartan Planning & Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spartan Planning & Wealth Management with notifications on news.